Notch signaling in pediatric malignancies

Current Oncology Reports

Volumn 10, Issue 6, 2008, Pages 459-468

  Zweidler McKay, Patrick A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; DEXAMETHASONE; GAMMA SECRETASE INHIBITOR; JAGGED1; MK 0752; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; PROTEIN KINASE B INHIBITOR; PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR MASH1; UNCLASSIFIED DRUG; VALPROIC ACID; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BREAST CANCER; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FATE; CELL SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DIARRHEA; DRUG MECHANISM; EWING SARCOMA; GENE MUTATION; HUMAN; MEDULLOBLASTOMA; METASTASIS; NEUROBLASTOMA; NONHUMAN; ONCOGENE; OSTEOSARCOMA; REVIEW; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

ANIMALS; CELL LINEAGE; CELL SURVIVAL; CHILD; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MEDICAL ONCOLOGY; MUTATION; NEOPLASM METASTASIS; OSTEOSARCOMA; PEDIATRICS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 58649089318     PISSN: 15233790     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11912-008-0071-2     Document Type: Review

References (50)

1. Leong KG, Karsan A: Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006, 107: 2223-2233.
2. Bolos V, Grego-Bessa J, de la Pompa JL: Notch signaling in development and cancer. Endocr Rev 2007, 28: 339-363.
3. Gridley T: Notch signaling and inherited disease syndromes. Hum Mol Genet 2003, 12(Spec 1): R9-R13.
4. Boyer-Di Ponio J, Wright-Crosnier C, Groyer-Picard MT, et al.: Biological function of mutant forms of JAGGED1 proteins in Alagille syndrome: Inhibitory effect on Notch signaling. Hum Mol Genet 2007, 16: 2683-2692.
5. Federico A, Bianchi S, Dotti MT: The spectrum of mutations for CADASIL diagnosis. Neurol Sci 2005, 26: 117-124.
6. Sparrow DB, Chapman G, Wouters MA, et al.: Mutation of the LUNATIC FRINGE gene in humans causes spondylocostal dysostosis with a severe vertebral phenotype. Am J Hum Genet 2006, 78: 28-37.
7. Wang Z, Wei J, Zhang X, et al.: A review and re-evaluation of an association between the NOTCH4 locus and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006, 141B: 902-906.
8. Jurynczyk M, Jurewicz A, Raine CS, et al.: Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis. J Immunol 2008, 180: 2634-2640.
9. Maillard I, Fang T, Pear WS: Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu Rev Immunol 2005, 23: 945-974.
10. Zweidler-McKay PA, Pear WS: Notch and T cell malignancy. Semin Cancer Biol 2004, 14: 329-340.
11. Aster JC, Pear WS, Blacklow SC: Notch signaling in leukemia. Annu Rev Pathol 2008, 3: 587-613.
12. Fan X, Eberhart CG: Medulloblastoma stem cells. J Clin Oncol 2008, 26: 2821-2827.
13. Zhang P, Yang Y, Zweidler-McKay PA, et al.: Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin Cancer Res 2008, 14: 2962-2969.
14. Baliko F, Bright T, Poon R, et al.: Inhibition of notch signaling induces neural differentiation in Ewing sarcoma. Am J Pathol 2007, 170: 1686-1694.
15. Schaefer KL, Eisenacher M, Braun Y, et al. Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy. Eur J Cancer 2008, 44: 699-709.
16. Zeng Q, Li S, Chepeha DB, et al.: Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 2005, 8: 13-23.
17. Funahashi Y, Hernandez SL, Das I, et al.: A notch1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Res 2008, 68: 4727-4735.
18. Siekmann AF, Covassin L, Lawson ND: Modulation of VEGF signalling output by the Notch pathway. Bioessays 2008, 30: 303-313.
19. Zweidler-McKay PA, He Y, Xu L, et al.: Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies. Blood 2005, 106: 3898-3906.
20. Zweidler-McKay PA, Lum JJ, Thompson CB, et al.: A critical role for the Bcl-2 pathway in Notch-mediated B cell apoptosis, where growth arrest is independent of the E2A, IL-3 and p21Waf1/p27Kip1 pathways. Presented at the 47th Annual Meeting of the American Society of Hematology. Atlanta, GA; December 10-13, 2005.
21. Nefedova Y, Cheng P, Alsina M, et al.: Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood 2004, 103: 3503-3510.
22. Nefedova Y, Sullivan DM, Bolick SC, et al.: Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood 2008, 111: 2220-2229.
23. Duechler M, Shehata M, Schwarzmeier JD, et al.: Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2. Leukemia 2005, 19: 260-267.
24. Jundt F, Probsting KS, Anagnostopoulos I, et al.: Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. Blood 2004, 103: 3511-3515.
25. Schwarzer R, Kaiser M, Acikgoez O, et al.: Notch inhibition blocks multiple myeloma cell-induced osteoclast activation. Leukemia 2008 Jun 5 [Epub ahead of print].
26. Chiaramonte R, Basile A, Tassi E, et al.: A wide role for NOTCH1 signaling in acute leukemia. Cancer Lett 2005, 219: 113-120.
27. Chiaramonte R, Calzavara E, Balordi F, et al.: Differential regulation of Notch signal transduction in leukaemia and lymphoma cells in culture. J Cell Biochem 2003, 88: 569-577.
28. Tohda S, Nara N: Expression of Notch1 and Jagged1 proteins in acute myeloid leukemia cells. Leuk Lymphoma 2001, 42: 467-472.
29. Tohda S, Kogoshi H, Murakami N, et al.: Diverse effects of the Notch ligands Jagged1 and Delta1 on the growth and differentiation of primary acute myeloblastic leukemia cells. Exp Hematol 2005, 33: 558-563.
30. Ye Q, Shieh JH, Morrone G, et al.: Expression of constitutively active Notch4 (Int-3) modulates myeloid proliferation and differentiation and promotes expansion of hematopoietic progenitors. Leukemia 2004, 18: 777-787.
31. Tohda S, Murata-Ohsawa M, Sakano S, et al.: Notch ligands, Delta-1 and Delta-4 suppress the self-renewal capacity and long-term growth of two myeloblastic leukemia cell lines. Int J Oncol 2003, 22: 1073-1079.
32. Nemoto N, Suzukawa K, Shimizu S, et al.: Identification of a novel fusion gene MLL-MAML2 in secondary acute myelogenous leukemia and myelodysplastic syndrome with inv(11)(q21q23). Genes Chromosomes Cancer 2007, 46: 813-819.
33. Chen PM, Yen CC, Wang WS, et al.: Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia. Int J Oncol 2008, 32: 1335-1341.
34. Sutphin RME Fang W, Miller C, et al.: Notch agonists: emerging as a feasible therapeutic approach in AML. Presented at the 48th Annual Meeting of the American Society of Hematology. Orlando, FL; December 9-12, 2006.
35. Wouters BJ, Jorda MA, Keeshan K, et al.: Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1. Blood 2007, 110: 3706-3714.
36. Keeshan K, Shestova O, Ussin L, et al.: Tribbles homolog 2 (Trib2) and HoxA9 cooperate to accelerate acute myelogenous leukemia. Blood Cells Mol Dis 2008, 40: 119-121.
37. Palomero T, McKenna K, O'Neil J, et al.: Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias. Leukemia 2006, 20: 1963-1966.
38. Soderholm H, Ortoft E, Johansson I, et al.: Human achaete-scute homologue 1 (HASH-1) is downregulated in differentiating neuroblastoma cells. Biochem Biophys Res Commun 1999, 256: 557-563.
39. Grynfeld A, Pahlman S, Axelson H: Induced neuroblastoma cell differentiation, associated with transient HES-1 activity and reduced HASH-1 expression, is inhibited by Notch1. Int J Cancer 2000, 88: 401-410.
40. Revet I, Huizenga G, Chan A, et al.: The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma. Exp Cell Res 2008, 314: 707-719.
41. Real P, Tosello V, Ai W, et al.: Inhibition of NOTCH1 signaling reverses glucocorticoid resistance in T-ALL. Presented at the 49th Annual Meeting of the American Society of Hematology. Atlanta, GA; December 8-11, 2007.
42. De Keersmaecker K, Lahortiga I, Mentens N, et al.: In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. Haematologica 2008, 93: 533-542.
43. Vilimas T, Mascarenhas J, Palomero T, et al.: Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat Med 2007, 13: 70-77.
44. Chan SM, Weng AP, Tibshirani R, et al.: Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia. Blood 2007, 110: 278-286.
45. Palomero T, Dominguez M, Ferrando AA: The role of the PTEN/AKT pathway in NOTCH1-induced leukemia. Cell Cycle 2008, 7: 965-970.
46. Moellering R, Cornejo M, Rocknik J, et al.: Direct inhibition of the Notch transactivation complex with synthetic constrained peptides in T-cell acute lymphoblastic leukemia. Presented at the 49th Annual Meeting of the American Society of Hematology. Atlanta, GA; December 8-11, 2007.
47. Stockhausen MT, Sjolund J, Manetopoulos C, et al.: Effects of the histone deacetylase inhibitor valproic acid on Notch signalling in human neuroblastoma cells. Br J Cancer 2005, 92: 751-759.
48. Greenblatt DY, Vaccaro AM, Jaskula-Sztul R, et al.: Valproic acid activates notch-1 signaling and regulates the neuroendocrine phenotype in carcinoid cancer cells. Oncologist 2007, 12: 942-951.
49. Chen J, Zacharek A, Li A, et al.: Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke. Stroke 2008, 39: 220-226.
50. Li L, Milner LA, Deng Y, et al.: The human homolog of rat Jagged1 expressed by marrow stroma inhibits differentiation of 32D cells through interaction with Notch1. Immunity 1998, 8: 43-55.